跳至主要内容
临床试验/NCT02191917
NCT02191917终止不适用

A Study of Respiratory Muscle Strength, Including Effort-Independent Measures, in Subjects With Late-Onset Pompe Disease

BioMarin Pharmaceutical2 个研究点 分布在 2 个国家目标入组 8 人开始时间: 2014年10月21日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
8
试验地点
2
主要终点
Maximal Inspiratory Pressure (MIP)

研究概览

简要总结

Study 701-201 is a study in patients with late-onset Pompe disease (LOPD). The study will test respiratory muscle strength initially and again after 24 weeks in subjects treated or not treated with BMN 701 .

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to provide written informed consent, after the nature of the study has been explained, and prior to any study-related procedures
  • Documented diagnosis with late-onset Pompe disease - At least 18 years of age at study entry
  • Willing and able to comply with all study procedures

排除标准

  • Requires ventilatory support while awake and in the upright position
  • Concurrent disease, medical condition, or extenuating circumstance that, in the opinion of the investigator, might compromise patient well-being, study completion, or data collection
  • Allergy to tools or procedures used for respiratory muscle testing

结局指标

主要结局

Maximal Inspiratory Pressure (MIP)

时间窗: Baseline, Week 28

Pulmonary measure of change in maximal inspiratory pressure (MIP)

次要结局

  • Maximal Expiratory Pressure (MEP)(Baseline, Week 28)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Study of Respiratory Muscle Strength in Patients... | 临床试验